Ormeloxifene

Indications	Oral Dysfunctional uterine bleeding *Adult:* 60 mg twice a wk for the 1st 12 wk and then 60 mg once a wk for up to next 12 wk. Oral Contraception *Adult:* Take 1 tablet (30 mg) twice a wk for the 1st 12 wk then 1 tablet (30 mg) once a wk from 13th wk onwards. Take 1st tablet on the 1st day of menstrual cycle. Follow dose irrespective of menstrual periods.
Contraindications	Polycystic ovarian disease, cervical hyperplasia, recent history of jaundice or hepatic impairment, severe allergic states, TB, renal impairment. Pregnancy and lactation.
Warnings / Precautions	Women who desire to be pregnant should discontinue taking the drug.
Adverse Reactions	Delayed menses.
Mechanism of Actions	Ormeloxifene acts on oestrogen receptors. It has a weak estrogenic and potent antiestrogenic actions. It is expected to exert a contraceptive effect and normalise the bleeding from uterine cavity by regularising the expression of oestrogen receptors on the endometrium. As a contraceptive, it prevents proliferation and decidualisation of the endometrium, enhances blastocyst formation and slightly increases embryo transport through the oviducts. Absorption: Well absorbed from the GI tract. Peak serum levels achieved in 4 hr. Distribution: Widely distributed in tissues. Little affinity to plasma proteins. Excretion: Terminal half-life: Approx 170 hr.
Available As	Ormeloxifene 30 mg Ormeloxifene 60 mg

Subscribe to our e-mail newsletter to receive updates.

Ormeloxifene Containing Brands

We are Developing Our database, More results coming soon.

Ormeloxifene is used in following diseases

We are Developing Our database, More results coming soon.

Drug - Drug Interactions of Ormeloxifene

We are Developing Our database, More results coming soon.